Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...
For the thousands of Americans living with non-muscle invasive bladder cancer (NMIBC), a newly approved therapy may provide an alternative to bladder removal surgery even after standard treatment ...
TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, consistent release of chemotherapy proved far more effective than traditional ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results